J Korean Ophthalmol Soc.  2005 Nov;46(11):1944-1950.

Topiramate-induced Acute Angle-Closure Glaucoma

Affiliations
  • 1Department of Ophthalmology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea. cwkee@smc.samsung.co.kr

Abstract

PURPOSE
We describe 2 cases of bilateral acute angle-closure glaucoma associated with topiramate, a drug that has recently been prescribed for epilepsy or weight reduction. METHODS: A 51-year-old man and a 27-year-old woman, previously devoid of ocular problems, visited the emergency room with blurry vision after taking topiramate for epilepsy and weight reduction, respectively. Thorough medical history taking and ocular examinations including ultrasound biomicroscopy were performed. RESULTS: Ultrasound biomicroscopy revealed supraciliary choroidal effusion causing forward displacement of the lens-iris diaphragm, which resulted in myopia, anterior chamber shallowing, and increased intraocular pressure by angle-closure. Discontinuation of topiramate and the administration of cycloplegics, steroids and pressure-lowering agents led to the resolution of the symptoms. CONCLUSIONS: An idiosyncratic reaction of topiramate may produce supraciliary choroidal effusion and ciliary body edema, resulting in anterior displacement of lens-iris diaphragm, increased myopia and acute angle-closure glaucoma. Thorough medical history taking and ocular examinations are necessary to rule out the drug-induced acute angle-closure glaucoma.

Keyword

Angle-closure glaucoma; Choroidal effusion; Myopia; Topiramate

MeSH Terms

Adult
Anterior Chamber
Choroid
Ciliary Body
Diaphragm
Edema
Emergency Service, Hospital
Epilepsy
Female
Glaucoma, Angle-Closure*
Humans
Intraocular Pressure
Medical History Taking
Microscopy, Acoustic
Middle Aged
Mydriatics
Myopia
Steroids
Weight Loss
Mydriatics
Steroids
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr